查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1500499

動物疫苗市場：按動物類型、技術、給藥途徑、分銷管道分類 - 全球預測 2024-2030

Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年動物疫苗市場規模為98.2億美元，預計2024年將達104億美元，2030年將達151.9億美元，複合年成長率為6.43%。

獸用疫苗是生物製備的物質，可以刺激動物的免疫系統並保護其免受某些疾病的侵害。這些疫苗的功能與人類疫苗類似，是將抗原（通常是去活化或減毒的病原體或其成分）引入動物體內。這種暴露會引發免疫反應，包括產生抗體、記憶細胞和其他防禦機制，使動物能夠對目標疾病產生免疫力而不會生病。寵物數量的增加、牲畜數量的增加、通用感染疾病意識的增強、動物疾病的快速增加以及動物健康投資的增加正在推動進一步的成長。但由於疫苗儲存成本高、運輸過程中難以維持疫苗活力，擴大市場有重大問題。由於寵物主人數量的增加和生物技術研究的進步，人們對食品安全的興趣日益濃厚，正在市場上創造巨大的商機。

主要市場統計
基準年[2023] 98.2億美元
預測年份 [2024] 104億美元
預測年份 [2030] 151.9億美元
複合年成長率（%） 6.43%

區域洞察

美洲的獸用疫苗採用率最高，主要是因為動物數量眾多以及動物健康意識的增加。當地動物衛生機構制定的各種法規和指南極大地推動了疫苗的採用。在歐洲、中東和非洲地區，歐洲在獸用疫苗的採用方面處於領先地位，該地區先進的醫療和技術基礎設施、強力的法律規範以及促進動物福利的舉措對這一成長做出了重大貢獻。隨著旨在改善獸醫衛生系統的投資和努力的增加，中東和非洲正在顯示出成長潛力。亞太地區畜牧業人口較多，寵物擁有率較高，獸用疫苗普及潛力大。快速的都市化和寵物擁有的增加，以及政府關於疾病預防的指令，正在推動市場擴張。在亞太地區國家，由於伴同性動物的飼養和認知的提高，都市區的疫苗接種普及不斷提高，人們對動物健康的興趣日益濃厚。

FPNV定位矩陣

FPNV 定位矩陣對於評估獸用疫苗市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對獸用疫苗市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該領域競爭性質的寶貴見解，包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在動物疫苗市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 飼養寵物和牲畜的數量增加
      • 動物慢性病和意外傷害發生率增加
      • 政府關於獸醫動物疫苗接種的舉措
    • 抑制因素
      • 疫苗開發、儲存和處理相關的高成本
    • 機會
      • 從減毒活疫苗到 DNA 疫苗的轉變
      • 加大獸用疫苗新開發研發投入
    • 任務
      • 與嚴格監管合規相關的擔憂
  • 市場區隔分析
    • 動物類型：增加使用疫苗預防牲畜疾病
    • 技術：增加去活化感測器的使用，減輕狂犬病、流感、鉤端螺旋體病等針對性疾病的負擔
    • 給藥途徑：鼻內給藥由於其易於使用和非侵入性而越來越受到青睞。
    • 分銷管道：提高獸醫院和診所的疫苗供應
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章動物疫苗市場：依動物類型

  • 水產養殖
  • 伴同性動物
  • 家畜

第7章動物疫苗市場：依技術分類

  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗
  • 類毒素疫苗

第8章動物疫苗市場：依給藥途徑分類

  • 靜脈
  • 鼻腔
  • 口服

第9章動物疫苗市場：依通路分類

  • 醫院/診所
  • 零售藥房

第10章美洲動物疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太動物疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲動物疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 默克動物保健公司推出 3 劑豬疫苗
    • IIL投資70億印度盧比在印度海得拉巴建立新的動物疫苗部門
    • 默克動物保健公司收購 Benk
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4316E4E89380

[196 Pages Report] The Veterinary Vaccines Market size was estimated at USD 9.82 billion in 2023 and expected to reach USD 10.40 billion in 2024, at a CAGR 6.43% to reach USD 15.19 billion by 2030.

Veterinary vaccines are biologically prepared substances that stimulate an animal's immune system to protect it from specific diseases. These vaccines function similarly to human vaccines by introducing antigens, typically inactivated or attenuated forms of pathogens or their components, into the animal's body. This exposure triggers an immune response, including producing antibodies, memory cells, and other defense mechanisms, so the animal can develop immunity to the targeted disease without getting sick. Increasing pet adoption, livestock population, rising awareness of zoonotic diseases, surging incidences of animal diseases, and escalating investments in animal health drive further growth. However, the high cost of vaccine storage and difficulties in maintaining the viability of vaccines during transport pose significant issues in the market expansion. The increasing count of in-house pets escalated the focus on food safety, and advancements in biotechnological research provide significant opportunities in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 9.82 billion
Estimated Year [2024] USD 10.40 billion
Forecast Year [2030] USD 15.19 billion
CAGR (%) 6.43%

Regional Insights

The Americas exhibits the highest adoption of veterinary vaccines, primarily due to the high animal population and increasing awareness of animal health. Various regulations and guidelines set by local animal health organizations have substantially driven vaccine adoption. In EMEA, Europe leads in adopting veterinary vaccines owing to the region's advanced medical and technological infrastructure, robust regulatory frameworks, and initiatives promoting animal welfare, significantly contributing to this growth. In the Middle East and Africa, increasing investments and efforts towards improving animal health care systems signify growth potential. APAC, home to a large livestock population and high pet ownership, presents significant potential for veterinary vaccine adoption. Rapid urbanization and increasing pet adoption rates facilitate market expansion alongside governmental directives on disease prevention. The APAC Countries have been increasingly focusing on animal health as urban areas report high vaccine adoption due to increasing companion animal ownership and awareness.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Veterinary Vaccines Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing number of companion animal and livestock ownership
      • Rising incidence of chronic diseases and accidental injuries in animals
      • Government initiatives for immunization of veterinary animals
    • Market Restraints
      • High cost associated with development, storage, and handling of vaccines
    • Market Opportunities
      • Shift from live attenuated vaccines to DNA vaccines
      • Rising investments and R&D for development of novel veterinary vaccines
    • Market Challenges
      • Concerns associated with stringent regulatory compliance
  • Market Segmentation Analysis
    • Animal Type: Rising usage of vaccines for disease prevention in livestock animals
    • Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
    • Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
    • Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Veterinary Vaccines Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Veterinary Vaccines Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Merck Animal Health launches 3-in-one swine vaccine

Merck introduced an innovative three-in-one vaccine, Circumvent CML, for Veterinary Vaccines. This groundbreaking vaccine effectively controls Porcine Circovirus Type 2a and 2d, Mycoplasma hyopneumoniae, and Lawsonia intracellularis diseases. It offers the added convenience of reduced volume in a single-dose administration, making it easier for producers to administer. [Published On: 2023-06-14]

IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore

Indian Immunologicals Ltd (IIL) is making a substantial investment of INR 700 crore to establish a state-of-the-art veterinary vaccine manufacturing facility in Hyderabad's Genome Valley. This greenfield facility focuses on producing vaccines for animal conditions such as foot and mouth disease and other emerging diseases. Once operational, the manufacturing plant will significantly increase IIL's FMD vaccine capacity from 300 million doses per annum to an impressive 600 million doses per annum. [Published On: 2022-10-11]

Merck Animal Health to Acquire Venc

Merck Animal Health has recently announced the signing of a definitive agreement to acquire Vence, developed virtual fencing for livestock management and rotational grazing in the context of veterinary vaccines. Vence's virtual fencing technology offers numerous benefits, including reducing the need for physical fencing and labor. It enables producers and ranchers to efficiently manage cattle movement and facilitate rotational grazing, all from the convenience of a computer or smartphone. [Published On: 2022-09-22]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Veterinary Vaccines Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Vaccines Market, highlighting leading vendors and their innovative profiles. These include Addison Biological Laboratory Inc., Aptimmune Biologics, Inc, Bimeda Inc., Biokema SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd, Covetrus, Inc., Elanco Animal Health Incorporated, Endovac Animal Health., Hester Biosciences Limited, HIPRA, S.A, Indian Immunologicals Ltd., Kemin Industries, Inc., Kyoritsuseiyaku Corporation, Laboratoire LCV, Meiji Holdings Co., Ltd., Merck & Co., Inc, Neogen Corporation, Norbrook Laboratories Limited, Phibro Animal Health Corporation, Saiba Animal Health AG, Sumitomo Pharma Animal Health Co., Ltd., Torigen Pharmaceuticals Inc., Vaxxinova International BV, Virbac SA, YEBIO BIOENGINEERING CO., LTD OF QINGDAO, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Animal Type
    • Aquaculture
    • Companion Animals
    • Livestock
      • Bovine
      • Porcine
      • Poultry
      • Small Ruminants
  • Technology
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
  • Route of Administration
    • Intravenous
    • Nasal
    • Oral
  • Distribution Channel
    • Hospitals & Clinics
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Rising incidence of chronic diseases and accidental injuries in animals
      • 5.1.1.3. Government initiatives for immunization of veterinary animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with development, storage, and handling of vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Shift from live attenuated vaccines to DNA vaccines
      • 5.1.3.2. Rising investments and R&D for development of novel veterinary vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with stringent regulatory compliance
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Animal Type: Rising usage of vaccines for disease prevention in livestock animals
    • 5.2.2. Technology: Increasing use of inactivated sensors to reduce the burden of target diseases such as rabies, influenza, and leptospirosis
    • 5.2.3. Route of Administration: Growing preference for nasal administration owing to its user-friendly and non-invasive nature
    • 5.2.4. Distribution Channel: Rising accessibility of vaccines across veterinary hospitals & clinics
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Veterinary Vaccines Market, by Animal Type

  • 6.1. Introduction
  • 6.2. Aquaculture
  • 6.3. Companion Animals
  • 6.4. Livestock

7. Veterinary Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. Inactivated Vaccines
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant Vaccines
  • 7.5. Toxoid Vaccines

8. Veterinary Vaccines Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Nasal
  • 8.4. Oral

9. Veterinary Vaccines Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Retail Pharmacies

10. Americas Veterinary Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Veterinary Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Merck Animal Health launches 3-in-one swine vaccine
    • 13.3.2. IIL to set up new animal vaccine unit in Hyderabad, India at INR 700 crore
    • 13.3.3. Merck Animal Health to Acquire Venc
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. VETERINARY VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VETERINARY VACCINES MARKET DYNAMICS
  • FIGURE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. VETERINARY VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VETERINARY VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY VACCINES MARKET SIZE, BY NASAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY VACCINES MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA VETERINARY VACCINES MARKET SIZE, BY ANIMAL TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA VETERINARY VACCINES MARKET SIZE,